Waymo and Uber reached a settlement Friday to end their blockbuster trade secrets fight over self-driving car technology, capping off a year of contentious discovery disputes, shocking revelations and numerous delays. Here's a play-by-play of how we got here.
In a stinging setback for Boston Scientific Corp., a federal judge has held that the medical device maker violated its agreements with Israel’s Medinol Ltd. when it set up a secret stent-making operation in Ireland in 1997.
A federal judge has tentatively approved a $75 million settlement agreement between GlaxoSmithKline PLC and a group of consumers and third-party payors who claimed the U.K. drug maker broke antitrust law by trying to block generic competition for the arthritis drug Relafen.
Talks between U.S. and Israeli officials over pharmaceutical intellectual property rights have collapsed amid increasing tension between multinational brand-name drug makers and Israel’s burgeoning generics industry.
In a development that could have implications for a series of trademark lawsuits against search engine Google, Yahoo!’s Overture Services has settled a lawsuit brought by insurance giant Geico over similar complaints.
A federal judge is expected to set the timetable next week for court hearings on the closely watched challenge to Sanofi-Aventis SA's top-selling blood-thinning drug Plavix.
Chip software maker Synopsys Inc. has agreed to buy rival Nassda Corp. for about $192 million in a deal driven by the acrimonious patent and trade-secrets litigation between the two companies.
Medical device maker Biosite Inc. has countersued Roche Diagnostics Corp. in the two rivals’ dispute over patents for technologies used in diagnostic tests.
Indian drug maker Ranbaxy Laboratories Ltd. has a launched a generic version of the anti-infective drug clarithromycin in the U.K. after winning a patent infringement lawsuit brought by U.S.-based Abbott Laboratories.
Brazilian health officials have once again threatened to break the patent on some AIDS drugs held by international drug companies.
Chip maker Analog Devices has settled two separate patent lawsuits brought against the company by telecom equipment maker Motorola and the inventor of a standard for dial-up modem technology.
Gerald J. Flattmann Jr. has left Fish & Neave to join as partner in the intellectual property practice of Kirkland & Elllis LLP’s New York office.
Two seasoned intellectual property litigators have quit Clifford Chance for Akin Gump with a team of associates, leaving the IP department of the world's largest law firm limping after a series of defections.
Japanese electronics maker Sony Corp. has agreed to pay at least $40 million to Ampex Corp. to settle a lawsuit over patents related to digital cameras.
The U.S. Supreme Court has refused to hear the University of Rochester’s appeal in its patent dispute with makers of cox-2 inhibitor pain killers, ending a legal battle that has cost the school $10 million.
Fresh from its settlement of a potentially distracting malpractice lawsuit, Townsend and Townsend and Crew is positioning itself for growth in Asia and is taking on Knobbe Martens Olson & Bear for the leadership mantle in the Western U.S.
Swiss agricultural biotech company Syngenta and U.S. rival DuPont have settled their litigation over patents for pest-resistant corn, on the eve of the opening of the trial in federal court in Delaware.
The patent war between South Korea’s LG Electronics and Japan’s Matsushita Electric Industrial Co. shows no sign of abating, with LG securing a ban Monday on Korean imports of the Japanese rival’s plasma panel displays.
GlaxoSmithKline has sent a letter to British Prime Minister Tony Blair, in which the U.K. drug maker urges Blair to use his presidency of the G8 group of industrialized nations to push through sweeping international patent reforms.
Indian drug makers have urged the government to stamp out patent evergreening by banning the patenting of “trivial changes” to “essentially similar” molecules, as the industry braces for the introduction of product patents in January.
Seven attorneys have left Washington, D.C.-based intellectual property firm Staas & Halsey, LLP to found a new boutique in the capital.